HR-8414-119
Referred to the House Committee on Energy and Commerce.
Sponsored by John Joyce (R-PA)
What it does
This bill would amend the Federal Food, Drug, and Cosmetic Act to prohibit foods that do not come from the lacteal secretion of hooved mammals from being labeled or sold using standardized dairy terms (such as "milk," "cheese," or "yogurt"). It would require the FDA to issue enforcement guidance within 180 days of enactment and to report to Congress on enforcement actions within two years. Any existing FDA guidance inconsistent with the new definition would immediately lose legal force.
Who benefits
Conventional dairy farmers and dairy industry producers who argue they face unfair competition from plant-based products using dairy terminology. Rural dairy-farming communities, particularly in states like Pennsylvania and New York. Consumers who supporters argue are confused by plant-based products using dairy names. Dairy industry trade associations and cooperatives.
Who is hurt
Manufacturers of plant-based milk alternatives (e.g., oat, almond, soy, coconut, and rice beverages) who would need to relabel and potentially rebrand products. Retailers carrying these products who may face compliance costs. Consumers who prefer plant-based alternatives and rely on familiar dairy terminology to compare products. Small and startup plant-based food companies with fewer resources to absorb relabeling costs. Potentially, lactose-intolerant consumers and those with dairy allergies who use these terms to navigate food choices.
Supporters argue
Supporters argue that existing FDA standards of identity have long defined "milk" as a product derived from dairy animals, and that plant-based products using these terms mislead consumers about nutritional content — for example, almond "milk" contains significantly less protein than cow's milk. They contend that consistent enforcement of existing law is necessary to protect both consumers making nutritional decisions and dairy farmers who compete under stricter labeling standards.
Opponents argue
Opponents argue that consumers are not meaningfully deceived by plant-based dairy terminology, pointing to studies and FTC survey data suggesting shoppers understand these products are not animal-derived. They contend the bill is primarily an economic protection measure for the conventional dairy industry rather than a consumer protection measure, and that restricting well-established product names would impose significant relabeling costs on manufacturers while disrupting consumer recognition of products they already understand.
Constitutional context
Congress has broad authority to regulate food labeling in interstate commerce under the Commerce Clause (Art. I, §8, cl. 3) and the Necessary and Proper Clause. This bill operates within the established framework of the Federal Food, Drug, and Cosmetic Act, which has long been upheld as a valid exercise of that authority. No significant constitutional tension is present, though post-Loper Bright (2024), courts would independently review any FDA enforcement guidance issued under this statute rather than deferring to the agency's interpretation.
Checks and balances
Congress gains authority by codifying a statutory definition, limiting FDA's prior discretion; the FDA retains enforcement power but must act within the new statutory definition, and affected manufacturers may challenge specific enforcement actions in federal court.
Historical precedent
Earlier versions of the DAIRY PRIDE Act were introduced in the 115th, 116th, and 117th Congresses but did not advance to a floor vote; the FDA also issued draft guidance on plant-based labeling in 2023 without resolving the naming question definitively.